Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 27 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR Low-Dose Pembrolizumab with Dose-Dense Chemotherapy Increases pCR as Neoadjuvant Treatment for Localised TNBC ESMO Advocates for Equal Access to Optimal Cancer Care for all Patients with Cancer at the 79th World Health Assembly Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma MOST POPULAR ESMO Manifesto – Translating Scientific Evidence Into Effective Public Health Policy October 20, 2023 Durvalumab Extends Lives of People with Early-Stage Small Cell Lung Cancer June 25, 2024 Zantac Contains A Cancer-Causing Chemical And Now Breast Cancer Patients Are... September 30, 2019 AI-Supported Mammography Screening Shows Favourable Outcomes Compared with Standard Double Reading February 12, 2026 Load more HOT NEWS A Remarkable Group of Patients with Haematological Disorders with No or... How Can Hormone Replacement Therapy for Menopause Impact My Cancer Risk? Laser-Based Device Detects and Kills Melanoma Cells in the Blood, Study... The Opioid Epidemic and Cancer Pain Management: A Conversation with Dr....
